AVI BioPharma, Inc. (AVII) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts AVII Hot Sheet
Price: $0.66 --0%
Financial Fact:
Research and development: 34.35M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 34.35M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
AVI BioPharma, Inc. (NASDAQ: AVII) reported Q2 EPS of $0.01, $0.08 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $11.6 million versus the consensus estimate of $13.67 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
